GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Additional Paid-In Capital

BioLife Solutions (STU:BJX1) Additional Paid-In Capital : €636.49 Mil(As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Additional Paid-In Capital?


BioLife Solutions's quarterly additional paid-in capital increased from Sep. 2024 (€606.54 Mil) to Dec. 2024 (€653.16 Mil) but then stayed the same from Dec. 2024 (€653.16 Mil) to Mar. 2025 (€636.49 Mil).

BioLife Solutions's annual additional paid-in capital increased from Dec. 2022 (€577.48 Mil) to Dec. 2023 (€598.69 Mil) and increased from Dec. 2023 (€598.69 Mil) to Dec. 2024 (€653.16 Mil).


BioLife Solutions Additional Paid-In Capital Historical Data

The historical data trend for BioLife Solutions's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Additional Paid-In Capital Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 248.74 518.08 577.48 598.69 653.16

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 606.34 620.39 606.54 653.16 636.49

BioLife Solutions Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

BioLife Solutions Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines